KOL Identification

Whether it’s a champion or a critic, insights from the right person will make all the difference. We can identify and connect you to the top, most influential minds in your space.

Our Experts

Pranay Madan

Katie Maloney

Carl Schoellhammer

Schedule a Call

Related Client Results

All Client Results

Life Science Tools & Manufacturing

Synthetic Oligonucleotides Market Sizing

A leader in synthetic oligonucleotide manufacturing wanted to assess the total market size and opportunity

View

No items found.

Diagnostics

Carrier Screening Landscape Assessment

A leading diagnostics player wanted an assessment of the current and future carrier screening landscape, primarily in the U.S., to guide their product development strategy

View

Voice-of-Customer Research

Pharma

Internal Lab Buildout Strategy

A large pharmaceutical company engaged DeciBio to evaluate strategies for an internal build of a lab to support clinical and commercial opportunities in oncology

View

Voice-of-Customer Research

Due Diligence

Investors

CDD on Novel Handheld Diagnostic Device Manufacturer

A global healthcare investment firm wanted to perform a commercial due diligence (CDD) prior to investment in a company producing a novel handheld diagnostic.

View

Voice-of-Customer Research

KOL Identification

Pricing Strategy

Revenue Projection

Due Diligence

Pharma

Cell and Gene Therapy Services Landscape Assessment

A top-10 scientific service provider wanted to quantify the size of the CGT services market and understand trends within

View

No items found.

Pharma

Global Companion Diagnostic Guideline Mapping and Strategy

A large pharma new to precision oncology wanted to understand the processes and requirements to ensure that their novel CDx was included into diagnostic guidelines globally

View

Biomarker and Diagnostics Strategy

Go-to-Market Strategy

Precision Medicine is evolving at a rapid pace

Discover how we can help

Get in Touch